North China Pharmaceutical Co Ltd (600812) — Financial Flexibility Index
North China Pharmaceutical Co Ltd (600812) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of CN¥314.62 Million (operating CF CN¥170.24 Million minus capex CN¥144.38 Million) represents 0% of total liabilities (CN¥14.86 Billion). Check asset allocation strategy of North China Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
North China Pharmaceutical Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for North China Pharmaceutical Co Ltd across 28 annual periods. See 600812 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for North China Pharmaceutical Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for North China Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of North China Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | CN¥1.72 Billion | CN¥1.18 Billion | CN¥14.51 Billion | ▼ -13.0% |
| 2024 | 0.14x | CN¥2.01 Billion | CN¥1.23 Billion | CN¥14.80 Billion | ▲ +21.3% |
| 2023 | 0.11x | CN¥1.65 Billion | CN¥1.02 Billion | CN¥14.69 Billion | ▲ +8.2% |
| 2022 | 0.10x | CN¥1.55 Billion | CN¥1.00 Billion | CN¥14.99 Billion | ▲ +16.2% |
| 2021 | 0.09x | CN¥1.60 Billion | CN¥1.05 Billion | CN¥17.91 Billion | ▼ -14.4% |
| 2020 | 0.10x | CN¥1.76 Billion | CN¥752.15 Million | CN¥16.88 Billion | ▼ -2.4% |
| 2019 | 0.11x | CN¥1.38 Billion | CN¥732.97 Million | CN¥12.92 Billion | ▲ +3.4% |
| 2018 | 0.10x | CN¥1.28 Billion | CN¥774.33 Million | CN¥12.40 Billion | ▲ +78.4% |
| 2017 | 0.06x | CN¥686.94 Million | CN¥287.25 Million | CN¥11.87 Billion | ▲ +509.8% |
| 2016 | -0.01x | CN¥-157.93 Million | CN¥-446.53 Million | CN¥11.18 Billion | ▼ -130.9% |
| 2015 | 0.05x | CN¥490.31 Million | CN¥122.50 Million | CN¥10.73 Billion | ▲ +35.2% |
| 2014 | 0.03x | CN¥348.86 Million | CN¥90.56 Million | CN¥10.32 Billion | ▼ -17.3% |
| 2013 | 0.04x | CN¥425.92 Million | CN¥-135.03 Million | CN¥10.41 Billion | ▼ -61.7% |
| 2012 | 0.11x | CN¥1.00 Billion | CN¥-63.92 Million | CN¥9.36 Billion | ▼ -22.1% |
| 2011 | 0.14x | CN¥1.36 Billion | CN¥227.60 Million | CN¥9.95 Billion | ▲ +94.9% |
| 2010 | 0.07x | CN¥558.27 Million | CN¥-598.35 Million | CN¥7.94 Billion | ▼ -67.3% |
| 2009 | 0.21x | CN¥1.38 Billion | CN¥1.01 Billion | CN¥6.41 Billion | ▼ -5.8% |
| 2008 | 0.23x | CN¥1.22 Billion | CN¥1.09 Billion | CN¥5.37 Billion | ▲ +55.9% |
| 2007 | 0.15x | CN¥762.64 Million | CN¥664.37 Million | CN¥5.22 Billion | ▲ +26.5% |
| 2006 | 0.12x | CN¥648.84 Million | CN¥597.12 Million | CN¥5.61 Billion | ▲ +56.8% |
| 2005 | 0.07x | CN¥408.84 Million | CN¥224.17 Million | CN¥5.55 Billion | ▼ -34.1% |
| 2004 | 0.11x | CN¥658.89 Million | CN¥310.39 Million | CN¥5.89 Billion | ▼ -50.7% |
| 2003 | 0.23x | CN¥1.02 Billion | CN¥580.32 Million | CN¥4.51 Billion | ▲ +1.1% |
| 2002 | 0.22x | CN¥963.19 Million | CN¥738.50 Million | CN¥4.29 Billion | ▲ +86.1% |
| 2001 | 0.12x | CN¥559.07 Million | CN¥367.28 Million | CN¥4.63 Billion | ▲ +70.6% |
| 2000 | 0.07x | CN¥231.00 Million | CN¥133.49 Million | CN¥3.27 Billion | ▲ +171.7% |
| 1999 | -0.10x | CN¥-285.87 Million | CN¥-373.62 Million | CN¥2.90 Billion | ▲ +32.3% |
| 1998 | -0.15x | CN¥-292.55 Million | CN¥-326.74 Million | CN¥2.01 Billion | — |